Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
AdaptHealth
(NASDAQ:AHCO)
Intraday
$9.91
0.33
[3.44%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$9.91
0.33
[3.44%]
Last update: 12:30PM
Get Real Time Here
Get Report
Watch
Q1 2024 Earnings in 11 days from now on Tue May 7th, before the market open
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for AdaptHealth Stock (NASDAQ:AHCO)
AdaptHealth Stock (NASDAQ: AHCO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 17, 2024
AdaptHealth Appoints Suzanne Foster As Chief Executive Officer, Will Assume Leadership Of The Company From Interim CEO And Chairman Of The Board, Richard Barasch, On May 20, 2024
Benzinga Newsdesk
-
Apr 17, 2024, 4:29PM
Tuesday, April 09, 2024
Philips (PHG) Boosts Patient Monitoring With SmartQare Deal
Zacks
-
Apr 9, 2024, 10:08AM
Monday, March 04, 2024
Peeling Back The Layers: Exploring AdaptHealth Through Analyst Insights
Benzinga Insights
-
Mar 4, 2024, 2:01PM
RBC Capital Reiterates Outperform on AdaptHealth, Maintains $13 Price Target
Benzinga Newsdesk
-
Mar 4, 2024, 11:09AM
Wednesday, February 28, 2024
UBS Maintains Buy on AdaptHealth, Raises Price Target to $13
Benzinga Newsdesk
-
Feb 28, 2024, 1:20PM
Truist Securities Maintains Buy on AdaptHealth, Raises Price Target to $13
Benzinga Newsdesk
-
Feb 28, 2024, 9:15AM
Tuesday, February 27, 2024
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Feb 27, 2024, 1:18PM
AdaptHealth shares are trading higher after the company reported Q4 financial results.
Benzinga Newsdesk
-
Feb 27, 2024, 12:18PM
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
Feb 27, 2024, 10:27AM
AdaptHealth Expects Fiscal Year 2024 Net Revenue Of $3.25B-$3.35B Versus Consensus Of $3.34B, With Adjusted EBITDA Of $650M-$710M
Benzinga Newsdesk
-
Feb 27, 2024, 7:06AM
AdaptHealth Q4 GAAP EPS $(1.91) May Not Be Comparable To $0.18 Estimate, Sales $858.23M Beat $825.44M Estimate
Benzinga Newsdesk
-
Feb 27, 2024, 7:05AM
Earnings Scheduled For February 27, 2024
Benzinga Insights
-
Feb 27, 2024, 5:01AM
Monday, January 29, 2024
In-Depth Examination Of 4 Analyst Recommendations For AdaptHealth
Benzinga Insights
-
Jan 29, 2024, 1:00PM
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9
Benzinga Newsdesk
-
Jan 29, 2024, 11:42AM
Thursday, December 21, 2023
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Dec 21, 2023, 1:01PM
Wednesday, November 08, 2023
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $13
Benzinga Newsdesk
-
Nov 8, 2023, 2:24PM
Analyst Expectations for AdaptHealth's Future
Benzinga Insights
-
Nov 8, 2023, 12:00PM
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $11-Report Released on 7th Nov
Benzinga Newsdesk
-
Nov 8, 2023, 10:56AM
B of A Securities Downgrades AdaptHealth to Underperform, Announces $6.5 Price Target
Benzinga Newsdesk
-
Nov 8, 2023, 10:55AM
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $11
Benzinga Newsdesk
-
Nov 8, 2023, 9:46AM
Tuesday, November 07, 2023
Why AdaptHealth Stock Trading Is Lower Today
Vandana Singh
-
Nov 7, 2023, 1:53PM
AdaptHealth Sees FY23 Net Revenue Of $3.16B-$3.185B Versus Prior Guidance Of $3.16B-$3.2B Versus Consensus Of $3.17B; Sees Adjusted EBITDA Of $630M-$650M Versus Prior Guidance Of $650M-$680M
Benzinga Newsdesk
-
Nov 7, 2023, 7:30AM
AdaptHealth Q3 EPS $(3.43) May Not Be Comparable To $0.19 Estimate, Sales $804.03M Beat $796.65M Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 7:01AM
Earnings Scheduled For November 7, 2023
Benzinga Insights
-
Nov 7, 2023, 6:34AM
Wednesday, October 11, 2023
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $14
Benzinga Newsdesk
-
Oct 11, 2023, 4:02PM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
Friday, September 22, 2023
Analyst Ratings for AdaptHealth
Benzinga Insights
-
Sep 22, 2023, 1:00PM
B of A Securities Maintains Neutral on AdaptHealth, Lowers Price Target to $11
Benzinga Newsdesk
-
Sep 22, 2023, 9:56AM
Thursday, August 17, 2023
AdaptHealth shares are trading lower after Linde filed a lawsuit against recently appointed CEO Crispin Teufel. The lawsuit does not name AdaptHealth as a defendant.
Benzinga Newsdesk
-
Aug 17, 2023, 3:03PM
What's Going On With AdaptHealth Stock Today?
Vandana Singh
-
Aug 17, 2023, 1:07PM
Why NICE Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Aug 17, 2023, 12:26PM
Tuesday, August 15, 2023
Chief Technology Officer at AdaptHealth Exercises Options Worth $2.75M
Benzinga Insights
-
Aug 15, 2023, 11:01AM
Tuesday, August 08, 2023
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Aug 8, 2023, 1:13PM
AdaptHealth shares are trading higher after the company reported better-than-expected Q2 revenue results and issued FY23 net revenue guidance above estimates.
Benzinga Newsdesk
-
Aug 8, 2023, 12:47PM
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Aug 8, 2023, 10:35AM
AdaptHealth Expects FY23 Net revenue of $3.16B-$3.20B Vs Consensus Of $3.14B (Prior View: $3.16B-$3.24B)
Benzinga Newsdesk
-
Aug 8, 2023, 6:37AM
AdaptHealth Q2 EPS $0.09 Misses $0.10 Estimate, Sales $793.29M Beat $765.20M Estimate
Benzinga Newsdesk
-
Aug 8, 2023, 6:32AM
Earnings Scheduled For August 8, 2023
Benzinga Insights
-
Aug 8, 2023, 4:48AM
Thursday, July 13, 2023
Analyst Ratings for AdaptHealth
Benzinga Insights
-
Jul 13, 2023, 8:01AM
Baird Maintains Outperform on AdaptHealth, Raises Price Target to $21
Benzinga Newsdesk
-
Jul 13, 2023, 7:52AM
Wednesday, June 28, 2023
Baird Reiterates Outperform on AdaptHealth, Maintains $20 Price Target
Benzinga Newsdesk
-
Jun 28, 2023, 10:03AM
Tuesday, June 27, 2023
Where AdaptHealth Stands With Analysts
Benzinga Insights
-
Jun 27, 2023, 3:01PM
Baird Reiterates Outperform on AdaptHealth, Maintains $20 Price Target
Benzinga Newsdesk
-
Jun 27, 2023, 12:28PM
AdaptHealth Appoints Crispin Teufel As CEO Effective September 1
Benzinga Newsdesk
-
Jun 27, 2023, 8:18AM
Thursday, June 15, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Jun 15, 2023, 2:53PM
Thursday, May 11, 2023
AdaptHealth Corp. Partners With Humana On Value-Based Care
Happy Mohamed
-
May 11, 2023, 2:02PM
Chief Executive Officer at AdaptHealth Exercises Options Worth $5.77M
Benzinga Insights
-
May 11, 2023, 11:01AM
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $18
Benzinga Newsdesk
-
May 11, 2023, 9:59AM
Wednesday, May 10, 2023
Expert Ratings for AdaptHealth
Benzinga Insights
-
May 10, 2023, 12:00PM
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Benzinga Insights
-
May 10, 2023, 11:00AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch